This year, at Davos some of the world’s most prominent psychedelic industry leaders and researchers will attend a satellite event that will run parallel to the World Economic Forum.
From May 21 through 26, the Medical Psychedelic Series at Davos will feature industry executives, drug development experts, clinicians, nonprofit organizations, advocates and influencers in the psychedelics space.
